|

New Hope for Treating Pleural Mesothelioma: Breakthrough Therapies on the Horizon

ByHolly Zink
New Hope for Treating Pleural Mesothelioma: Breakthrough Therapies on the Horizon

Pleural mesothelioma is a rare and tough cancer with a history of limited treatment options and a difficult prognosis. But recent years have brought good news for patients, as new treatments give hope to those facing this challenging condition.

A Positive Shift in Treatment

Since 2021, a big change has happened in how we treat pleural mesothelioma. Doctors now use immune checkpoint inhibitors as the first choice for treatment. These include nivolumab and ipilimumab. This is a big step forward for patients who once had few options for this tough cancer.

Combining chemotherapy and immune checkpoint inhibitors is a good next step. But researchers are also exploring other ways to treat pleural mesothelioma. They are learning more about how this cancer starts. This helps them develop treatments that target the disease more directly.

Scientists are testing new methods like viral therapy and antibody-drug combinations. And they are using special cells called CAR-T cells and dendritic cells to fight cancer. These new ideas have the potential to change the lives of patients, thanks to what we’ve learned from clinical trials.

What Experts Think

In the future, doctors plan to learn even more about pleural mesothelioma. They are going to do this by testing patients again after their disease gets worse. This helps them find new changes in the cancer’s makeup and understand how different treatments work. By understanding why some treatments stop working, doctors can come up with new and better ways to help patients.

What You Need to Know

Doctors now use a combination of two types of immune therapy, anti-PD1 and anti-CTLA4, as the first treatment. This is giving new hope to pleural mesothelioma patients. New treatments like cancer virus therapy and CAR-T cell therapy have shown promise. They directly target pleural mesothelioma, where it’s found in the body.

Researchers are working on treatments that are customized for each patient. This might help make treatments more effective and precise. Doctors are also looking into using special medicines and combinations to fight pleural mesothelioma. Although more work is needed, it’s a hopeful idea.

The future of treating pleural mesothelioma may involve using a mix of these. It may use new treatments along with immune therapy to make them work better. Using special lab models will help find new treatments. And retesting patients will help us understand how to improve treatment even more.

In Conclusion

Pleural mesothelioma, once a very tough cancer to treat, is now getting better options. With the introduction of immune checkpoint inhibitors and ongoing research into new treatments, there’s a lot of hope for patients and their families. Each new discovery takes us a step closer to improving the lives of those dealing with this rare and challenging cancer. It’s a positive sign in the fight against pleural mesothelioma.

Source:

Assié, Jean-Baptiste, and Didier Jean. “Pleural Mesothelioma: A Snapshot of Emerging Drug Targets and Opportunities for Non-Surgical Therapeutic Advancement.” Expert Opinion on Therapeutic Targets, October 30, 2023, 1–11. https://doi.org/10.1080/14728222.2023.2277224.

Similar Posts

  • | |

    Macrophages May Hold Key to Fighting Mesothelioma

    ByAlex Strauss

    Researchers in Western Australia are investigating new ways of bolstering the immune system in an effort to fight cancers like mesothelioma. Like most types of cancer, malignant mesothelioma occurs primarily in people over 65. That is also the time in life when the immune system typically weakens. Researchers from Curtin University and the University of Western Australia say it is no coincidence that people become more susceptible to mesothelioma as their immunity wanes. In addition to age-related immune dysfunction, mesothelioma patients experience a further decline in immunity caused by the growing tumor itself. To better understand the connection between declining immunity and the onset of mesothelioma, the researchers are focusing on a particular type of immune system cell called a macrophage….

  • |

    Mesothelioma Symptoms May Benefit from Tuberculosis Drugs

    ByAlex Strauss

    Pleural effusion is the one of most uncomfortable and life-limiting symptoms of pleural mesothelioma. The buildup of fluid in the pleural space around the lungs, which can happen in late stage mesothelioma as well as several other types of cancer, limits breathing and can be painful. Effusion is often one of the primary reasons that mesothelioma patients in the late stages of the disease have trouble taking a full breath and complain of chest pain and fatigue. While pleural fluid can be drained off through thoracentesis or chemically absorbed through pleurodesis, these treatments are painful, risky, and not always effective. Now, a team of researchers in China say they may have discovered a non-invasive method for dealing with pleural effusion caused…

  • |

    Asbestos Mesothelioma Risk Increased By Other Fibers

    ByAlex Strauss

    Asbestos is a fibrous mineral mined and used for decades in products ranging from insulation to cement, floor and ceiling tiles, adhesives, and friction products. It has been more than forty years since scientists confirmed the link between asbestos and malignant pleural mesothelioma, an aggressive cancer of the lining around the lungs and its use is now heavily regulated in the U.S. In recent years, another mineral called erionite, has also been implicated in mesothelioma cases. Now, a study conducted in France suggests that two other types of mineral particles used in industry may increase the risk of mesothelioma, particularly in people who are also exposed to asbestos. Researchers in Bordeaux, France compared the cases of 1,199 male industrial workers with…

  • |

    Localized Mesothelioma May Provide Longer Survival

    ByAlex Strauss

    Patients with a rare, localized form of pleural mesothelioma may have a better survival outlook than patients with the more common, diffuse variety. That conclusion comes from a team of thoracic surgeons at Cambridge University. Their goal was to determine what, if any, difference in survival could be expected between people with localized malignant mesothelioma (LMM) of the pleura and those with standard pleural mesothelioma. Most pleural mesothelioma patients have a type of cancer that tends to spread quickly in a sheet across the thin membrane that surrounds the lungs. While patients with LMM have identical mesothelioma cells, from a histological perspective, the growth pattern exhibited by these cells is distinctly different. Instead of spreading across the mesothelium, LMM presents as…

  • |

    Pleurodesis for Mesothelioma: Hard to Predict Success

    ByAlex Strauss

    Pleurodesis is a procedure often used to help relieve some of the symptoms of pleural mesothelioma, but there is still no way to predict how effective it will be in any individual patient. That is the conclusion of Australian researchers who performed a retrospective study on 390 mesothelioma patients enrolled in the Western Australian Mesothelioma Registry over 5 years. Just over 42% of those patients underwent pleurodesis. The procedure is used to reduce pleural effusions, the buildup of fluid between the layers of lung lining that can cause shortness of breath, cough, and chest pain. Pleurodesis for mesothelioma can be performed either surgically or chemically. Surgical pleurodesis involves mechanically irritating the parietal pleura, causing it to swell and adhere to the visceral…

  • |

    Implantable Catheter May Provide Mesothelioma Symptom Relief

    ByAlex Strauss

    An implantable catheter that allows cancer patients to drain their own excess lung fluid at home may improve quality of life for some mesothelioma patients. A company-sponsored study of the PleurX drainage system conducted in Germany and published in a German medical journal, suggests that the system may be especially beneficial for late-stage mesothelioma patients. Pleural mesothelioma is a malignancy of the pleural lining which surrounds the lungs. In its later stages, mesothelioma often results in pleural effusions, or a build-up of fluid in the space between the inner and outer parts of the pleura. The problem is also common in the later stages of lung cancer and breast cancer. Pleural effusions limit the ability of the lungs to expand, resulting in…